SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-23-000063
Filing Date
2023-10-26
Accepted
2023-10-26 16:07:07
Documents
13
Period of Report
2023-10-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20231026x8k.htm   iXBRL 8-K 44314
2 EX-99.1 tmb-20231026xex99d1.htm EX-99.1 176080
  Complete submission text file 0001070081-23-000063.txt   355609

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20231026.xsd EX-101.SCH 3127
4 EX-101.LAB tmb-20231026_lab.xml EX-101.LAB 15269
5 EX-101.PRE tmb-20231026_pre.xml EX-101.PRE 9660
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231026x8k_htm.xml XML 4721
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 231350205
SIC: 2834 Pharmaceutical Preparations